4th Quarter - Report — PFIZER INC. for PFIZER INC. (2020)

Firm

PFIZER INC.

Client

PFIZER INC.

Income

—

Expenses

$2,380,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Foreign Market Access Issues (including IPR) NAFTA/USMCA International Supply Chain/Buy America U.S.- U.K. Trade Negotiations U.S. - Kenya FTA

Lobbyist	Covered position, as disclosed
ELISSA ALBEN	—
PAULA BURG	—
STEPHEN CLAEYS	—
ANGELA WALKER RIEMER	—
CATHERINE ROBINSON	—

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); State, Dept of (DOS); Natl Economic Council (NEC); Office of the Vice President of the United States; Commerce, Dept of (DOC); White House Office

Taxation/Internal Revenue Code TAX

Comprehensive Corporate Tax Reform International Tax Reform OECD Profit Allocation Manufacturing Credits

Lobbyist	Covered position, as disclosed
ANGELA WALKER RIEMER	—
CAROLINE MOODY SCHELLHAS	—

Contacted: State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Treasury, Dept of; Office of Management & Budget (OMB); SENATE; White House Office; Commerce, Dept of (DOC); Natl Economic Council (NEC); Food & Drug Administration (FDA); Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Executive Office of the President (EOP)

Medicare/Medicaid MMM

Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Price Transparency International Reference Pricing/Most Favored Nations

Lobbyist	Covered position, as disclosed
PAULA BURG	—
JOSEPH TUCKER KNOTT	—
EMILY MUELLER	—
ANGELA WALKER RIEMER	—
JENNIFER SWENSON WALTON	—

Contacted: U.S. Trade Representative (USTR); Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); State, Dept of (DOS); Commerce, Dept of (DOC); Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); White House Office; Office of Management & Budget (OMB); Executive Office of the President (EOP); Treasury, Dept of

Health Issues HCR

Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Rebate Reform Vaccine Infrastructure Drug Importation

Lobbyist	Covered position, as disclosed
PAULA BURG	—
JOSEPH TUCKER KNOTT	—
EMILY MUELLER	—
ANGELA WALKER RIEMER	—
JENNIFER SWENSON WALTON	—

Contacted: Commerce, Dept of (DOC); White House Office; Natl Economic Council (NEC); Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States; Food & Drug Administration (FDA); SENATE; State, Dept of (DOS); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Office of Management & Budget (OMB)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.